Burning Rock Biotech Ltd
Qualité des données : 100%
BNR
NASDAQ
Services
Health Services
17,93 €
▲
1,82 €
(11,30%)
Cap. Boursière: 176,79 M
Prix
16,42 €
Cap. Boursière
176,79 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—
Quick Summary
Points Clés
Revenue grew 1,77% annually over 5 years — modest growth
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -13,38 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 8,41%
Capital efficient — spends only 1,05% of revenue on capex
Croissance
Revenue Growth (5Y)
1,77%
En dessous de la moyenne du secteur (3,76%)
Revenue (1Y)-6,64%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-50,57%
En dessous de la moyenne du secteur (-15,95%)
ROIC-39,86%
Net Margin-67,20%
Op. Margin-69,32%
Sécurité
Debt / Equity
0,00
En dessous de la moyenne du secteur (0,39)
Current Ratio4,07
Interest CoverageN/A
Valorisation
PE (TTM)
-3,72
En dessous de la moyenne du secteur (-1,19)
P/B Ratio0,83
EV/EBITDAN/A
Dividend YieldN/A
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Services (515 pairs)
Comparaison Sectorielle
vs médiane du secteur Services (515 pairs)| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -3,7 | -1,2 |
| P/B | 0,8 | 1,4 |
| ROE % | -50,6 | -16,0 |
| Net Margin % | -67,2 | -18,3 |
| Rev Growth 5Y % | 1,8 | 3,8 |
| D/E | 0,0 | 0,4 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
Aucune estimation prévisionnelle disponible
No quarterly estimates available
Surprises de Résultats
Derniers 4 trimestres
| Trimestre | BPA Est. | BPA Réel | Surprise |
|---|---|---|---|
| Q12023 | -13,90 € | -18,10 € | -30,2% |
| Q42022 | -19,00 € | -21,10 € | -11,1% |
| Q32022 | -18,80 € | -23,30 € | -23,9% |
| Q22022 | -18,50 € | -25,00 € | -35,1% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -6,64% | Revenue Growth (3Y) | -6,98% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 1,77% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 70,67 M | Net Income (TTM) | -47,49 M |
| ROE | -50,57% | ROA | -35,47% |
| Gross Margin | 70,25% | Operating Margin | -69,32% |
| Net Margin | -67,20% | Free Cash Flow (TTM) | -13,38 M |
| ROIC | -39,86% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 4,07 |
| Interest Coverage | N/A | Asset Turnover | 0,53 |
| Working Capital | 164,77 M | Tangible Book Value | 213,33 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -3,72 | Forward P/E | N/A |
| P/B Ratio | 0,83 | P/S Ratio | 2,50 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -7,57% | ||
| Market Cap | 176,79 M | Enterprise Value | 5,66 M |
| Per Share | |||
| EPS (Diluted TTM) | N/A | Revenue / Share | 6,56 |
| FCF / Share | -1,24 | OCF / Share | -1,17 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 1,05% | FCF Conversion | 28,18% |
| SBC-Adj. FCF | -34,70 M | Growth Momentum | -8,41 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 70,67 M | 75,70 M | 81,66 M | 79,69 M | 65,89 M |
| Net Income | -47,49 M | -92,07 M | -140,82 M | -125,02 M | -62,41 M |
| EPS (Diluted) | — | — | — | — | — |
| Gross Profit | 49,65 M | 51,16 M | 55,10 M | 57,14 M | 48,11 M |
| Operating Income | -48,99 M | -94,27 M | -142,15 M | -125,08 M | -63,21 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 31,82 M | 48,88 M | 61,17 M | 57,73 M | 40,45 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 7,15 M | 18,79 M | 17,99 M | 7,50 M | 5,11 M |
| Interest Expense | 0,0 | 0,0 | 15 000,0 | 241 000,0 | 102 000,0 |
| Income Tax | 806 000,0 | 336 000,0 | 288 000,0 | 141 000,0 | 0,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 121,29 M | 146,48 M | 230,16 M | 357,56 M | 408,13 M |
| Total Liabilities | 41,71 M | 38,25 M | 62,22 M | 67,99 M | 37,09 M |
| Shareholders' Equity | 79,57 M | 108,23 M | 167,94 M | 289,57 M | 371,04 M |
| Total Debt | — | — | 0,0 | 372 000,0 | 1,13 M |
| Cash & Equivalents | 71,22 M | 86,63 M | 131,28 M | 224,61 M | 290,47 M |
| Current Assets | 106,40 M | 124,52 M | 182,50 M | 285,75 M | 386,77 M |
| Current Liabilities | 36,48 M | 37,10 M | 59,66 M | 58,41 M | 37,02 M |
{"event":"ticker_viewed","properties":{"ticker":"BNR","listing_kind":"stock","pathname":"/stocks/bnr","exchange":"NASDAQ","country":"US"}}
